PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
68.30%
Net income growth above 1.5x AVGO's 7.20%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-0.61%
Negative yoy D&A while AVGO is 2.70%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
625.00%
Well above AVGO's 101.63% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
-7.25%
Negative yoy SBC while AVGO is 18.18%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-10.48%
Negative yoy working capital usage while AVGO is 166.67%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-339.68%
AR is negative yoy while AVGO is 70.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
64.84%
Some inventory rise while AVGO is negative at -2600.00%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-251.35%
Negative yoy AP while AVGO is 362.50%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
155.86%
Growth well above AVGO's 87.76%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
50.33%
Operating cash flow growth similar to AVGO's 51.80%. Walter Schloss would see parallel improvements or market conditions in cash generation.
-41.75%
Both yoy lines negative, with AVGO at -19.15%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
100.00%
Acquisition growth of 100.00% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-70.78%
Negative yoy purchasing while AVGO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
43.18%
Liquidation growth of 43.18% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-100.00%
We reduce yoy other investing while AVGO is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
18.89%
We have mild expansions while AVGO is negative at -19.15%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-91.67%
We cut debt repayment yoy while AVGO is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-73.75%
Negative yoy issuance while AVGO is 240.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.